You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
北陸藥業(300016.SZ):上半年淨利降18.26%至9156.38萬元
格隆匯 08-07 18:03

格隆匯 8 月 7日丨北陸藥業(300016.SZ)披露2020年半年度報告,實現營業收入3.68億元,同比下降8.44%;歸屬於上市公司股東的淨利潤9156.38萬元,同比下降18.26%;歸屬於上市公司股東的扣除非經常性損益後的淨利潤7783.32萬元,同比下降25.37%;基本每股收益0.19元。

公司持續打造更加專業、高效的銷售團隊進行自營產品的銷售和推廣,同時通過優化招商策略及代理管理模式,搭建完善的商業渠道網絡進行代理產品的銷售。報告期內,受新冠肺炎疫情影響,全國各地醫院積極抗擊疫情,藥品銷售終端需求受到明顯影響;此外,物流運輸受到一定程度管控,也導致公司業績較去年同期有所下降。現階段,隨着國內疫情緩解,患者階段性推後的就醫需求逐步釋放,公司將有針對性開展市場推廣工作,力爭將疫情對公司的影響降至最低。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account